TISMOO BIOTECH LABORATÓRIO LTDA. – Trademark Portfolio
Entity Type: 13
TISMOO BIOTECH LABORATÓRIO LTDA. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include TISMOO. The owner is based in Cidade de São Paulo-SP.
Av Brigadeiro Luis Antonio, 2503
Conjuntos 21, 22, 23 e 24
Cidade de São Paulo-SP 01401-000 , BR
Showing of trademarks Trademarks
Trademark Classifications
TISMOO BIOTECH LABORATÓRIO LTDA.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does TISMOO BIOTECH LABORATÓRIO LTDA. have?
TISMOO BIOTECH LABORATÓRIO LTDA. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does TISMOO BIOTECH LABORATÓRIO LTDA. file in?
TISMOO BIOTECH LABORATÓRIO LTDA. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are TISMOO BIOTECH LABORATÓRIO LTDA.'s most well-known trademarks?
TISMOO BIOTECH LABORATÓRIO LTDA.'s registered trademark portfolio includes well-known marks such as TISMOO. These are among 1 currently registered trademark in the portfolio.
What is TISMOO BIOTECH LABORATÓRIO LTDA.'s trademark registration success rate?
TISMOO BIOTECH LABORATÓRIO LTDA. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.